Log In
Print
BCIQ
Print
Print this Print this
 

levorphanol extended release (LevoCap ER) (formerly TQ-1020)

  Manage Alerts
Collapse Summary General Information
Company Relmada Therapeutics Inc.
DescriptionOnce-daily, extended-release levorphanol in an abuse deterrent drug delivery system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat moderate to severe chronic pain; Treat pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today